Ipsen Biopharma

INCRELEX

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / INCRELEX – J2170

Manufacturer:

Ipsen Biopharma

Name:

INCRELEX

HCPCS Code Descriptor:

Injection, mecasermin, 1 mg

Category:

J Code

HCPCS:

J2170

NDC(s):

15054-1040-05

Primary Type:

Growth Disorder

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

INCRELEX is a Growth Disorder drug manufactured by Ipsen Biopharma and administered via the Subcutaneous route of administration. The J Code: J2170 is aligned to the drug INCRELEX.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/07

HCPCS Effective Date:

1/1/07

HCPCS Short Description:

Mecasermin injection

Billing and Coding Guide:

https://www.ipsencares.com/sites/g/files/kcxpwu526/files/2022-08/INC-US-001135-Increlex-Coding-Flashcard-November-2020_approved_1.21.21.pdf

Patient Assistance:

http://www.ipsencares.com/